IL268929A - Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes - Google Patents

Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes

Info

Publication number
IL268929A
IL268929A IL26892919A IL26892919A IL268929A IL 268929 A IL268929 A IL 268929A IL 26892919 A IL26892919 A IL 26892919A IL 26892919 A IL26892919 A IL 26892919A IL 268929 A IL268929 A IL 268929A
Authority
IL
Israel
Prior art keywords
purified
compositions
terpenes
cannabinoids
purposefully selected
Prior art date
Application number
IL26892919A
Other languages
English (en)
Hebrew (he)
Inventor
Aron Levy Kurt
Michael Cooper Jonathan
Reed Martin Jonathan
Geoffrey Reid Brian
Original Assignee
Canopy Growth Corp
Aron Levy Kurt
Michael Cooper Jonathan
Reed Martin Jonathan
Geoffrey Reid Brian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/616,874 external-priority patent/US20170266153A1/en
Application filed by Canopy Growth Corp, Aron Levy Kurt, Michael Cooper Jonathan, Reed Martin Jonathan, Geoffrey Reid Brian filed Critical Canopy Growth Corp
Publication of IL268929A publication Critical patent/IL268929A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL26892919A 2017-03-01 2019-08-26 Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes IL268929A (en)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US201762465688P 2017-03-01 2017-03-01
US201762469415P 2017-03-09 2017-03-09
US201762475153P 2017-03-22 2017-03-22
US201762477990P 2017-03-28 2017-03-28
US201762489360P 2017-04-24 2017-04-24
US201762490567P 2017-04-26 2017-04-26
US201762490465P 2017-04-26 2017-04-26
US201762491175P 2017-04-27 2017-04-27
US201762491160P 2017-04-27 2017-04-27
US201762491899P 2017-04-28 2017-04-28
US201762491980P 2017-04-28 2017-04-28
US201762509651P 2017-05-22 2017-05-22
US201762510229P 2017-05-23 2017-05-23
US201762510660P 2017-05-24 2017-05-24
US201762510672P 2017-05-24 2017-05-24
US201762511218P 2017-05-25 2017-05-25
US15/616,874 US20170266153A1 (en) 2015-02-27 2017-06-07 Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
PCT/US2018/020440 WO2018160827A1 (en) 2017-03-01 2018-03-01 Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes

Publications (1)

Publication Number Publication Date
IL268929A true IL268929A (en) 2019-10-31

Family

ID=63370542

Family Applications (1)

Application Number Title Priority Date Filing Date
IL26892919A IL268929A (en) 2017-03-01 2019-08-26 Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes

Country Status (10)

Country Link
EP (1) EP3589129A4 (es)
CN (1) CN110582206A (es)
AU (1) AU2018227544A1 (es)
BR (1) BR112019018088A2 (es)
CA (1) CA3054690A1 (es)
CO (1) CO2019009413A2 (es)
IL (1) IL268929A (es)
MX (1) MX2019010370A (es)
PE (1) PE20200383A1 (es)
WO (1) WO2018160827A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019147690A1 (en) 2018-01-23 2019-08-01 High Sierra Technologies, Inc. Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons
IL266151A (en) * 2019-04-18 2019-07-31 Kanabo Res Ltd Dilute for the cannabinoid preparations
WO2021012044A1 (en) 2019-07-22 2021-01-28 Canopy Growth Corporation Continuous crystallization of cannabinoids in a stirred-tank reactor
JP2023508257A (ja) * 2019-11-26 2023-03-02 ライコレッド リミテッド． カンナビノイドおよびリコピンの抗炎症性の相乗的組み合わせ
CN115605289A (zh) * 2020-04-29 2023-01-13 利加尔有限合伙公司（Nz） 印迹聚合物及其使用方法
EP4188915A1 (en) * 2020-07-27 2023-06-07 Canopy Growth Corporation Methods of synthesizing cannabielsoin and analogs thereof
WO2022165165A1 (en) * 2021-01-29 2022-08-04 The Johns Hopkins University Limonene effects on tetrahydrocannabinol (thc)-induced anxiety
CN113368086B (zh) * 2021-08-11 2021-12-03 龙麻(上海)医药研发有限责任公司 一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用
WO2023245185A1 (en) * 2022-06-17 2023-12-21 New Growth Brands, Inc. Compositions comprising cannabinoids and methods of preparation and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
TWI583374B (zh) * 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
ES2784229T3 (es) * 2013-11-20 2020-09-23 Panag Pharma Inc Composiciones y procedimientos para el tratamiento de la inflamación y el dolor ocular
MX2017010872A (es) * 2015-02-27 2018-05-07 Ebbu Llc Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.

Also Published As

Publication number Publication date
WO2018160827A1 (en) 2018-09-07
PE20200383A1 (es) 2020-02-24
BR112019018088A2 (pt) 2020-03-24
EP3589129A1 (en) 2020-01-08
CO2019009413A2 (es) 2019-09-09
AU2018227544A1 (en) 2019-08-29
CA3054690A1 (en) 2018-09-07
MX2019010370A (es) 2019-10-22
EP3589129A4 (en) 2020-11-25
CN110582206A (zh) 2019-12-17

Similar Documents

Publication Publication Date Title
IL268929A (en) Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
IL286693A (en) Combined stress response modulator compounds, preparations containing them and their uses
IL263676A (en) Methods and preparations for reducing oxidative stress
IL254025B (en) Compositions containing a mixture of pure cannabinoids with at least one flavonoid, terpene or mineral
SG11202011015QA (en) Fusosome compositions and uses thereof
HK1251922A1 (zh) 抗微生物組合物及其用途
EP3478308A4 (en) CANNABIS-BASED COMPOSITION AND PROCESSES
IL271275A (en) Preparations containing coronas and their uses
IL270776A (en) CBLB endonuclease variants, compositions and methods of use
SG11202001725SA (en) Synthetic cannabidiol compositions and methods of making the same
SI3580561T1 (sl) Metode, osnovane na hla, in njihove sestave ter uporabe
EP3634390A4 (en) ANTIMICROBIAL COMPOSITIONS INCLUDING CANNABINOIDS AND THEIR METHODS OF USE
IL312612A (en) Senolytic preparations and their uses
SG11201803669UA (en) Microorganism-controlling agent and miticidal composition
IL278881A (en) Cannabinoids and their use
IL287929A (en) Cannabinoids and their uses
IL283850A (en) Cannabis compounds and methods
GB201608762D0 (en) Compositions and uses thereof
IL273988A (en) Compounds of cannabidiol and chitosan, and methods for their use
EP3568203C0 (en) COMPOUNDS AND COMPOSITIONS
IL277663A (en) Arunumab preparations and their uses
GB201821138D0 (en) Compositions and uses thereof
ZA201706950B (en) Antibacterial compositions and methods
GB201602409D0 (en) Compositions and uses thereof
GB201812952D0 (en) Compositions and uses thereof